Income tax expense · 2018–2025
Castle Biosciences income tax expense
−$5.4M−$8.7M · FY2025
Castle Biosciences (CSTL) reported −$5.4M in income tax expense for fiscal 2025, −$8.7M from the year before.
| Fiscal year | Income tax expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | −$5.4M | −$8.7M | Open → |
| FY20242024-12-31 | $3.3M | +3,186.1% | Open → |
| FY20232023-12-31 | $101,000 | +$1.9M | Open → |
| FY20222022-12-31 | −$1.8M | +$7.0M | Open → |
| FY20212021-12-31 | −$8.7M | −$8.8M | Open → |
| FY20202020-12-31 | $84,000 | +16.7% | Open → |
| FY20192019-12-31 | $72,000 | +700.0% | Open → |
| FY20182018-12-31 | $9,000 | — | Open → |
Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Income tax expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Castle Biosciences income tax expense |url=https://companiesranked.com/en/company/castle-biosciences/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Castle Biosciences income tax expense. CompaniesRanked. https://companiesranked.com/en/company/castle-biosciences/income-tax-expenseBibTeX
@misc{companiesranked-en-company-castle-biosciences-income-tax-expense-2026,
author = {{CompaniesRanked}},
title = {{Castle Biosciences income tax expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/castle-biosciences/income-tax-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-012272 · February 26, 2026
{{cite web |title=Castle Biosciences income tax expense — 10-K (0001628280-26-012272) |url=https://www.sec.gov/Archives/edgar/data/1447362/000162828026012272/cstl-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.